Tinavi Medical Technologies Co Ltd (688277) - Net Assets
Based on the latest financial reports, Tinavi Medical Technologies Co Ltd (688277) has net assets worth CN¥1.19 Billion CNY (≈ $174.43 Million USD) as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥1.64 Billion ≈ $240.51 Million USD) and total liabilities (CN¥451.55 Million ≈ $66.08 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore 688277 total asset value for the complete picture of this company's asset base.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | CN¥1.19 Billion |
| % of Total Assets | 72.53% |
| Annual Growth Rate | 46.97% |
| 5-Year Change | 181.61% |
| 10-Year Change | 2100.57% |
| Growth Volatility | 95.82 |
Tinavi Medical Technologies Co Ltd - Net Assets Trend (2013–2025)
This chart illustrates how Tinavi Medical Technologies Co Ltd's net assets have evolved over time, based on quarterly financial data. Check Tinavi Medical Technologies Co Ltd tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Annual Net Assets for Tinavi Medical Technologies Co Ltd (2013–2025)
The table below shows the annual net assets of Tinavi Medical Technologies Co Ltd from 2013 to 2025. For live valuation and market cap data, see how much is Tinavi Medical Technologies Co Ltd worth.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | CN¥3.01 Billion ≈ $439.93 Million |
+134.85% |
| 2024-12-31 | CN¥1.28 Billion ≈ $187.32 Million |
+3.44% |
| 2023-12-31 | CN¥1.24 Billion ≈ $181.09 Million |
+10.73% |
| 2022-12-31 | CN¥1.12 Billion ≈ $163.54 Million |
+4.68% |
| 2021-12-31 | CN¥1.07 Billion ≈ $156.22 Million |
+4.00% |
| 2020-12-31 | CN¥1.03 Billion ≈ $150.22 Million |
+72.14% |
| 2019-12-31 | CN¥596.34 Million ≈ $87.26 Million |
+6.37% |
| 2018-12-31 | CN¥560.61 Million ≈ $82.04 Million |
+230.92% |
| 2017-12-31 | CN¥169.41 Million ≈ $24.79 Million |
+24.00% |
| 2016-12-31 | CN¥136.62 Million ≈ $19.99 Million |
-33.02% |
| 2015-12-31 | CN¥203.98 Million ≈ $29.85 Million |
+286.03% |
| 2014-12-31 | CN¥52.84 Million ≈ $7.73 Million |
+78.49% |
| 2013-12-31 | CN¥29.60 Million ≈ $4.33 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Tinavi Medical Technologies Co Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 73257071389.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Other Comprehensive Income | CN¥1.25 Billion | 96.67% |
| Other Components | CN¥778.33 Million | 60.24% |
| Total Equity | CN¥1.29 Billion | 100.00% |
Tinavi Medical Technologies Co Ltd Competitors by Market Cap
The table below lists competitors of Tinavi Medical Technologies Co Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
IGB Bhd
KLSE:5606
|
$1.19 Billion |
|
Companhia Siderúrgica Nacional
SA:CSNA3
|
$1.19 Billion |
|
Elemental Royalties Corp
V:ELE
|
$1.19 Billion |
|
Borr Drilling Ltd
NYSE:BORR
|
$1.19 Billion |
|
Shanxi Huaxiang Group Co Ltd
SHG:603112
|
$1.19 Billion |
|
Gosuncn Technology Group Co Ltd Class A
SHE:300098
|
$1.19 Billion |
|
Harbin Xinguang Optic Electronics
SHG:688011
|
$1.19 Billion |
|
Jiuzhitang Co Ltd
SHE:000989
|
$1.19 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Tinavi Medical Technologies Co Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 1,267,845,501 to 1,292,073,782, a change of 24,228,281 (1.9%).
- Net loss of 184,031,800 reduced equity.
- Dividend payments of 7,178,118 reduced retained earnings.
- Other comprehensive income increased equity by 858,057,403.
- Other factors decreased equity by 642,619,204.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | CN¥-184.03 Million | -14.24% |
| Dividends Paid | CN¥7.18 Million | -0.56% |
| Other Comprehensive Income | CN¥858.06 Million | +66.41% |
| Other Changes | CN¥-642.62 Million | -49.74% |
| Total Change | CN¥- | 1.91% |
Book Value vs Market Value Analysis
This analysis compares Tinavi Medical Technologies Co Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 6.19x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 18.07x to 6.19x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2013-12-31 | CN¥0.99 | CN¥17.81 | x |
| 2014-12-31 | CN¥1.74 | CN¥17.81 | x |
| 2015-12-31 | CN¥1.07 | CN¥17.81 | x |
| 2016-12-31 | CN¥0.91 | CN¥17.81 | x |
| 2017-12-31 | CN¥0.95 | CN¥17.81 | x |
| 2018-12-31 | CN¥1.78 | CN¥17.81 | x |
| 2019-12-31 | CN¥1.40 | CN¥17.81 | x |
| 2020-12-31 | CN¥2.38 | CN¥17.81 | x |
| 2021-12-31 | CN¥2.40 | CN¥17.81 | x |
| 2022-12-31 | CN¥2.49 | CN¥17.81 | x |
| 2023-12-31 | CN¥2.77 | CN¥17.81 | x |
| 2024-12-31 | CN¥2.78 | CN¥17.81 | x |
| 2025-12-31 | CN¥2.88 | CN¥17.81 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Tinavi Medical Technologies Co Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -14.24%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -64.97%
- • Asset Turnover: 0.17x
- • Equity Multiplier: 1.33x
- Recent ROE (-14.24%) is below the historical average (-6.84%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2013 | 21.30% | 15.10% | 1.01x | 1.40x | CN¥3.35 Million |
| 2014 | -29.83% | -40.66% | 0.58x | 1.27x | CN¥-21.05 Million |
| 2015 | -9.37% | -64.44% | 0.11x | 1.29x | CN¥-31.94 Million |
| 2016 | -18.83% | -100.59% | 0.14x | 1.36x | CN¥-39.39 Million |
| 2017 | 13.67% | 29.56% | 0.12x | 3.93x | CN¥5.82 Million |
| 2018 | -0.16% | -0.68% | 0.19x | 1.20x | CN¥-55.94 Million |
| 2019 | -5.29% | -13.49% | 0.32x | 1.22x | CN¥-89.49 Million |
| 2020 | -5.47% | -40.08% | 0.12x | 1.12x | CN¥-154.07 Million |
| 2021 | -7.94% | -51.23% | 0.12x | 1.27x | CN¥-180.63 Million |
| 2022 | -10.60% | -70.80% | 0.11x | 1.35x | CN¥-214.95 Million |
| 2023 | -12.64% | -74.46% | 0.13x | 1.31x | CN¥-280.14 Million |
| 2024 | -9.55% | -67.73% | 0.11x | 1.33x | CN¥-247.91 Million |
| 2025 | -14.24% | -64.97% | 0.17x | 1.33x | CN¥-313.24 Million |
Industry Comparison
This section compares Tinavi Medical Technologies Co Ltd's net assets metrics with peer companies in the Medical Instruments & Supplies industry.
Industry Context
- Industry: Medical Instruments & Supplies
- Average net assets among peers: $1,634,145,730
- Average return on equity (ROE) among peers: 6.15%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Tinavi Medical Technologies Co Ltd (688277) | CN¥1.19 Billion | 21.30% | 0.38x | $1.19 Billion |
| Beijing Centergate Technologies Holding Co Ltd (000931) | $1.67 Billion | -1.81% | 1.12x | $456.25 Million |
| Blue Sail Medical Co Ltd (002382) | $1.05 Billion | 5.90% | 0.53x | $881.70 Million |
| Andon Health Co Ltd (002432) | $1.57 Billion | 0.81% | 0.24x | $4.94 Billion |
| Allmed Medical Products Co Ltd Class A (002950) | $3.13 Billion | 12.99% | 0.84x | $873.85 Million |
| Guangzhou Improve Med Instrument (300030) | $78.73 Million | 25.99% | 0.80x | $305.40 Million |
| QITIAN Technology Group Co Ltd (300061) | $471.02 Million | -17.67% | 1.36x | $640.31 Million |
| Shanghai Tofflon Science Tech (300171) | $3.24 Billion | 4.50% | 0.61x | $1.44 Billion |
| Truking Technology Ltd (300358) | $4.32 Billion | -10.48% | 2.08x | $962.69 Million |
| Jiangxi Sanxin Medtec Co Ltd (300453) | $122.42 Million | 28.61% | 0.63x | $729.59 Million |
| Shenyang Xingqi Pharmaceutical Co Ltd (300573) | $694.06 Million | 12.68% | 0.39x | $1.54 Billion |
About Tinavi Medical Technologies Co Ltd
Tinavi Medical Technologies Co.,Ltd. engages in the research and development, production, sale, market, service, and clinical application of orthopedic surgery robots and related technologies. The company offers TiRobot II, an orthopedic robotic system to create an operation center; TiRobot, an orthopedic robotic system used in implants in surgery for spine and trauma; 5G remote surgery systems; … Read more